<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mem Inst Oswaldo Cruz</journal-id><journal-id journal-id-type="iso-abbrev">Mem. Inst. Oswaldo Cruz</journal-id><journal-id journal-id-type="publisher-id">mioc</journal-id><journal-title-group><journal-title>Mem&#x000f3;rias do Instituto Oswaldo Cruz</journal-title></journal-title-group><issn pub-type="ppub">0074-0276</issn><issn pub-type="epub">1678-8060</issn><publisher><publisher-name>Instituto Oswaldo Cruz, Minist&#x000e9;rio da Sa&#x000fa;de</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5293122</article-id><article-id pub-id-type="publisher-id">0074-02760160361</article-id><article-id pub-id-type="doi">10.1590/0074-02760160361</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group></article-categories><title-group><article-title>Linalool, a <italic>Piper aduncum</italic> essential oil component, has selective activity against <italic>Trypanosoma cruzi</italic> trypomastigote forms at 4&#x000b0;C</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Villamizar</surname><given-names>Luz Helena</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Cardoso</surname><given-names>Maria das Gra&#x000e7;as</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>de Andrade</surname><given-names>Juliana</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Teixeira</surname><given-names>Maria Luisa</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Soares</surname><given-names>Maurilio Jos&#x000e9;</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="corresp" rid="c01">
<sup>+</sup>
</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Funda&#x000e7;&#x000e3;o Oswaldo Cruz-Fiocruz, Instituto Carlos Chagas, Laborat&#x000f3;rio de Biologia Celular, Curitiba, PR, Brasil</aff><aff id="aff2"><label>2</label>Universidade Federal de Lavras, Departamento de Qu&#x000ed;mica, Lavras, MG, Brasil</aff><author-notes><corresp id="c01"><label>+</label> Corresponding author: <email>maurilio@fiocruz.br</email></corresp><fn fn-type="con"><p>AUTHORS&#x02019; CONTRIBUTION</p><p>LHV designed and performed the biological screening experiments (single drug activity assays on <italic>Trypanosoma cruzi</italic> developmental forms, cytotoxicity, flow cytometry) and drafted the manuscript; JA and MLT were responsible for the <italic>Piper aduncum</italic> essential oil purification and chemical analysis; MJS and MGC supervised, analysed the data and edited the manuscript.</p></fn></author-notes><pub-date pub-type="epub-ppub"><month>2</month><year>2017</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><month>2</month><year>2017</year></pub-date><volume>112</volume><issue>2</issue><fpage>131</fpage><lpage>139</lpage><history><date date-type="received"><day>10</day><month>8</month><year>2016</year></date><date date-type="accepted"><day>1</day><month>11</month><year>2016</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p> This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </license-p></license></permissions><abstract><sec><title>BACKGROUND</title><p> Recent studies showed that essential oils from different pepper species (<italic>Piper</italic> spp.) have promising leishmanicidal and trypanocidal activities.</p></sec><sec><title>OBJECTIVES</title><p> In search for natural compounds against <italic>Trypanosoma cruzi</italic>, different forms of the parasite were incubated for 24 h at 28&#x000ba;C or 4&#x000ba;C with <italic>Piper aduncum</italic> essential oil (<italic>Pa</italic>EO) or its main constituents linalool and nerolidol.</p></sec><sec><title>METHODS</title><p>
<italic>Pa</italic>EO chemical composition was obtained by GC-MS. Drug activity assays were based on cell counting, MTT data or infection index values. The effect of <italic>Pa</italic>EO on the <italic>T. cruzi</italic> cell cycle and mitochondrial membrane potential was evaluated by flow cytometry.</p></sec><sec><title>FINDINGS</title><p>
<italic>Pa</italic>EO was effective against cell-derived (IC<sub>50</sub>/24 h: 2.8 &#x003bc;g/mL) and metacyclic (IC<sub>50</sub>/24 h: 12.1 &#x003bc;g/mL) trypomastigotes, as well as intracellular amastigotes (IC<sub>50</sub>/24 h: 9 &#x003bc;g/mL). At 4&#x000ba;C - the temperature of red blood cells (RBCs) storage in blood banks - cell-derived trypomastigotes were more sensitive to <italic>Pa</italic>EO (IC<sub>50</sub>/24 h = 3.8 &#x003bc;g/mL) than to gentian violet (IC<sub>50</sub>/24 h = 24.7 mg/mL). Cytotoxicity assays using Vero cells (37&#x000ba;C) and RBCs (4&#x000ba;C) showed that <italic>Pa</italic>EO has increased selectivity for cell-derived trypomastigotes. Flow cytometry analysis showed that <italic>Pa</italic>EO does not affect the cell cycle of <italic>T. cruzi</italic> epimastigotes, but decreases their mitochondrial membrane potential. GC-MS data identified nerolidol and linalool as major components of <italic>P</italic>aEO, and linalool had trypanocidal effect (IC<sub>50</sub>/24 h: 306 ng/mL) at 4&#x000ba;C.</p></sec><sec><title>MAIN CONCLUSION</title><p> The trypanocidal effect of <italic>Pa</italic>EO is likely due to the presence of linalool, which may represent an interesting candidate for use in the treatment of potentially contaminated RBCs bags at low temperature.</p></sec></abstract><kwd-group><kwd>essential oil</kwd><kwd>linalool</kwd><kwd>Piper aduncum</kwd><kwd>Trypanosoma cruzi</kwd><kwd>trypanocidal activity</kwd></kwd-group><counts><fig-count count="2"/><table-count count="4"/><equation-count count="0"/><ref-count count="54"/><page-count count="9"/></counts></article-meta></front><body><p>The protozoan <italic>Trypanosoma cruzi</italic> is the etiologic agent of Chagas disease, a neglected tropical illness that is endemic in 21 Latin American countries (<xref rid="B53" ref-type="bibr">WHO 2016</xref>), and has spread to five continents, mainly due to immigration (<xref rid="B48" ref-type="bibr">Schmunis &#x00026; Yadon 2010</xref>). Chagas disease has no effective treatment and affects about 7-8 million people worldwide (<xref rid="B53" ref-type="bibr">WHO 2016)</xref>, with about five million of those in Brazil (<xref rid="B45" ref-type="bibr">Salomon 2012)</xref>. <italic>T. cruzi</italic> transmission routes include contact with infected blood-sucking insects (<xref rid="B41" ref-type="bibr">Rassi et al. 2009)</xref>, blood transfusion (<xref rid="B5" ref-type="bibr">Assal &#x00026; Corbi 2011)</xref>, vertical transfer from mother to fetus (<xref rid="B29" ref-type="bibr">Jackson et al. 2009)</xref>, organ and tissue transplantation (<xref rid="B19" ref-type="bibr">Fishman &#x00026; Rubin 1998</xref>, <xref rid="B48" ref-type="bibr">Schmunis &#x00026; Yadon 2010)</xref>, contact with infected conjunctiva or oral mucosa (<xref rid="B23" ref-type="bibr">Giddings et al. 2006)</xref>, and laboratory accidents (<xref rid="B25" ref-type="bibr">Herwaldt 2001)</xref>.</p><p>Benznidazole (BZ) is the drug commonly used to treat individuals with Chagas disease (<xref rid="B39" ref-type="bibr">Raj&#x000e3;o et al. 2014</xref>). Treatment with BZ has approximately 80% efficacy in the acute phase and 20% in the chronic phase of the disease (<xref rid="B41" ref-type="bibr">Rassi et al. 2009</xref>). The side effects of BZ - which include allergic dermatitis, paresthesia, thrombocytopenia and leucopenia - lead to treatment discontinuation in 7-13% of cases (<xref rid="B9" ref-type="bibr">Bern 2011</xref>). Despite decades of efforts to obtain less toxic, easily accessible (and relatively inexpensive) drugs against Chagas disease, no effective molecule or compound, whether natural or synthetic, has yet been identified that could replace BZ in the clinic, to improve the quality of life of affected patients (<xref rid="B44" ref-type="bibr">Romanha et al. 2010</xref>).</p><p>From the natural products currently tested against <italic>T. cruzi</italic> the most studied alternatives are of plant origin (<xref rid="B14" ref-type="bibr">Coura &#x00026; de Castro 2002</xref>). The trypanocidal activity of approximately 400 plants species (over 100 plant families) has been analysed in the last two decades (<xref rid="B28" ref-type="bibr">Izumi et al. 2012)</xref>. Nevertheless, relatively few reports have assessed the anti-trypanocidal activity of essential oils (EOs) (<xref rid="B3" ref-type="bibr">Alviano et al. 2012)</xref>, volatile and aromatic compounds produced (as secondary metabolites) by all plant organs. In plants, EOs function as antiseptics and biocides, protecting not only against pathogenic microorganisms but also against herbivores. Due to their pleasant odor and low toxicity profile, several EOs are widely used in perfumes, food products and herbal medicines (<xref rid="B7" ref-type="bibr">Bakkali et al. 2008)</xref>. EOs, or their major constituents, represent promising candidates for the development of drugs against <italic>T. cruzi</italic>. A number of different EOs are active against <italic>T. cruzi</italic> and not appreciably toxic to mammalian cells (<xref rid="B10" ref-type="bibr">Borges et al. 2012)</xref>.</p><p>Peppers (<italic>Piper</italic> spp., Piperaceae) form a large genus of plants (&#x0003e; 700 species) widespread in tropical and subtropical regions of the world, and used in traditional medicine as analgesic, antiseptic and antimicrobial agents (<xref rid="B38" ref-type="bibr">Orjala et al. 1994</xref>, <xref rid="B54" ref-type="bibr">Xu &#x00026; Li 2011)</xref>. Whole extracts or purified molecules derived from a variety of pepper species have activity against <italic>Leishmania</italic> and <italic>Trypanosoma</italic>, usually in the 10-20 &#x000b5;g/mL range (<xref rid="B32" ref-type="bibr">Lopes et al. 2008</xref>, <xref rid="B42" ref-type="bibr">Regasini et al. 2009</xref>, <xref rid="B22" ref-type="bibr">Garcia et al. 2013)</xref>. Pepper EOs are also active against trypanosomatid parasites. <italic>Piper auritum</italic> EO inhibits the proliferation of promastigotes of <italic>Leishmania major</italic>, <italic>L. mexicana</italic>, <italic>L. braziliensis</italic> and <italic>L. donovani</italic>, with IC<sub>50</sub> values (for 72 h treatments) between 12.8 and 63.3 &#x000b5;g/mL (<xref rid="B34" ref-type="bibr">Monzote et al. 2010)</xref>. Also <italic>P. hispidum</italic> EO showed promising results (high antileishmanial activity with low cytotoxicity, and a safety index of eight) when treating <italic>L. amazonensis</italic>-infected macrophages (<xref rid="B26" ref-type="bibr">Hou&#x000eb;l et al. 2015)</xref>. The EO of <italic>P. cubeba</italic> was not active against <italic>L. amazonensis</italic>, but was effective against <italic>T. cruzi</italic>, with IC<sub>50</sub> values of 45.5 and 87.9 &#x000b5;g/mL, for trypomastigote and amastigote forms, respectively (<xref rid="B18" ref-type="bibr">Esperandim et al. 2013)</xref>.</p><p>
<italic>P. aduncum</italic> (common names: &#x02018;aperta-ru&#x000e3;o&#x02019;, &#x02018;jaborandi-falso&#x02019;, &#x02018;pimento-de-macaco&#x02019; and &#x02018;matico&#x02019;) is a tropical bush typical from Central and South America. In Brazil it is found naturally in the Amazon and Atlantic Forests. <italic>P. aduncum</italic> extracts inhibits the proliferation of <italic>T. cruzi</italic> epimastigotes in vitro, with IC<sub>50</sub> concentrations lower than 20 &#x000b5;g/mL (<xref rid="B20" ref-type="bibr">Flores et al. 2009</xref>). Also, five chromenes isolated from <italic>P. aduncum</italic> have anti-proliferative activity against <italic>T. cruzi</italic> epimastigotes, with IC<sub>50</sub> values of 2.82 &#x000b5;M, after 72 h of treatment (<xref rid="B8" ref-type="bibr">Batista Jr et al. 2008</xref>), suggesting that the anti-trypanocidal activity of this plant should be analysed further. Despite the trypanocidal activity of <italic>P. aduncum</italic> extracts, no studies have yet tested the effect of <italic>P. aduncum</italic> EOs against <italic>T. cruzi</italic>.</p><p>Here, we analysed the trypanocidal effect of <italic>P. aduncum</italic> EO (<italic>Pa</italic>EO) against different developmental forms of <italic>T. cruzi</italic>, in bioassays for 24 h. Gas chromatography-mass spectrometry (GC-MS) data identified nerolidol and linalool as the major components of this essential oil, and linalool had strong trypanocidal effect (IC<sub>50</sub>/24 h: 306 ng/mL) at 4&#x000ba;C. The promising trypanocidal effect of <italic>Pa</italic>EO is likely due to the presence of linalool, which may be used as a lead for further drug development.</p><sec sec-type="materials|methods"><title>MATERIALS AND METHODS</title><p>
<italic>Vero cells</italic> - Vero cells (ATCC CCL-81) were grown in RPMI-1640 medium with L-glutamine (Sigma Aldrich, St. Louis, MO, USA), supplemented with 5% fetal calf serum (FCS; Cultilab, Campinas, SP, Brazil), at 37&#x000ba;C, and in a humidified 5% CO<sub>2</sub> atmosphere. For seeding, cell monolayers were washed twice with PBS (pH 7.2), trypsinized and collected by centrifugation at 100 <italic>g</italic> for 2 min.</p><p>
<italic>Parasites</italic> - In this work, we used the <italic>T. cruzi</italic> clone Dm28c. Epimastigote forms were kept at 28&#x000ba;C in LIT medium supplemented with 10% inactivated FCS, with passages at every three days. For the experiments, parasites obtained from 72-h cultures were used.</p><p>To obtain cell-derived trypomastigotes, Vero cells were incubated with cell-derived trypomastigotes (1:10 ratio of cells to parasites) in 75 cm<sup>2</sup> culture flasks containing 8 mL DMEM. After 4 h of interaction, non-internalised parasites were removed by rinsing with phosphate-buffered saline (PBS), new medium was added, and then changed to fresh medium every 24 h. After 96 h of infection, trypomastigotes released into the supernatant were collected by centrifugation at 3000 <italic>g</italic> for 10 min.</p><p>To obtain metacyclic trypomastigotes, culture epimastigotes in late logarithmic growth phase (five days) were subjected to nutritional stress as described previously (<xref rid="B12" ref-type="bibr">Contreras et al. 1985</xref>). Culture epimastigotes (5-7 x 10<sup>7</sup> cells/mL) were collected by centrifugation at 7000 <italic>g</italic> for 5 min at 10&#x000ba;C, and resuspended in TAU medium (Triatomine Artificial Urine: 190 mM NaCl, 17 mM KCl, 2 mM MgCl<sub>2</sub>, 2 mM CaCl<sub>2</sub>, 8 mM phosphate buffer pH 6.0), at a concentration of 5 x 10<sup>8</sup> cells/mL. After incubation for 2 h at 28&#x000ba;C (nutritional stress), parasites were transferred to 25 cm<sup>2</sup> flasks containing 5 mL TAU3AAG medium (TAU supplemented with 10 mM L-proline, 50 mM sodium glutamate, 2 mM sodium aspartate and 10 mM glucose), at a final concentration of 5 x 10<sup>6</sup> cells/mL. After 72 h, metacyclic trypomastigotes in the supernatant (~80% parasites) were collected by centrifugation and purified by passage through a DEAE-cellulose affinity column, equilibrated in PSG buffer (47.47 mM Na<sub>2</sub>HPO<sub>4</sub>, 2.5 mM NaH<sub>2</sub>PO<sub>4</sub>.H<sub>2</sub>0, 37.76 mM NaCl, 55.5 mM glucose).</p><p>
<italic>P. aduncum essential oil (PaEO) purification and chemical analysis</italic> - <italic>P. aduncum</italic> L. (matico) leaves were collected on March 2013 in the morning, with no rain, at the Medicinal Plants Garden of the Universidade Federal de Lavras (UFLA, MG, Brazil). <italic>P. aduncum</italic> EO was obtained by distillation in a Clevenger equipment, at the Department of Chemistry, Federal University of Lavras. Prior to use in experiments, <italic>Pa</italic>EO was diluted to 100 mg/mL in DMSO (<italic>Pa</italic>EO stock solution). Final DMSO concentrations in activity assays did not exceed 0.5%. Both undiluted and diluted (stock) <italic>Pa</italic>EO were kept at 4&#x000ba;C, and in the dark.</p><p>
<italic>Pa</italic>EO chemical analysis was performed in the Department of Chemistry of UFLA, in a GC-17A Shimadzu gas chromatograph coupled to a QP 5000 Shimadzu mass spectrometer, with a selective detector. The column used was of fused silica/bound type (DB5, 30m x 0.25mm), with helium (1 mL/min) as the mobile-phase gas. The following analysis conditions were used: injection at 220&#x000ba;C, detection at 240&#x000ba;C; oven temperature between 40&#x000ba;C and 240&#x000ba;C, with addition of 3&#x000ba;C/min; initial column pressure of 100.2 kPa; 1:10 split ratio and injected volume of 1 &#x000b5;L (solutions at 1% v/v) in dichloromethane. Mass spectra of each compound were compared with the Wiley 229 library database, and with the tabulated Kovats index.</p><p>
<italic>Single drug activity assays on T. cruzi developmental forms</italic> - All experiments were performed in biological and technical triplicates. Incubations were performed for 24 h in all bioassays. The absorbance of untreated cells in culture media containing 0.5% DMSO (control) was used as 100% cell viability, and the percentage of dead cells in each treatment was estimated by comparison with the untreated control.</p><p>For all assays, IC<sub>50</sub>/24 h values (based on cell counting, MTT data or infection index values) and dose-response curves were generated using the CompuSyn software (ComboSyn Inc., Paramus, NJ, USA), and statistical analysis was performed in Excel. For all assays, the fraction of affected cells (Fa) was calculated relative to the untreated control (treated/untreated ratio).</p><p>To test the activity of <italic>Pa</italic>EO on epimastigote forms, these cells were seeded into 96-well plates (5 x 10<sup>6</sup> cells/well) in LIT medium, and treated for 24 h at 28&#x000ba;C with <italic>Pa</italic>EO at the final concentrations of 9, 18, 37, 75, 150 and 300 &#x000b5;g/mL. As a control, BZ (at 6.25, 12.5, 25 or 50 &#x000b5;g/mL) or LIT medium with 0.5% DMSO (negative control) were used. Cell viability was assessed by the MTT assay (see &#x0201c;MTT assay&#x0201d;).</p><p>
<italic>Pa</italic>EO activity assays with cell-derived trypomastigotes were performed at 28&#x000ba;C and 4&#x000ba;C. Cell-derived trypomastigotes (5 x 10<sup>7</sup> cells/well) were seeded in 96-well plates with DMEM, and treated with <italic>Pa</italic>EO or BZ at the final concentrations 1, 10, 50 and 100 &#x000b5;g/mL, or with gentian violet (1 and 25 &#x000b5;M; for 4&#x000ba;C experiments only). Untreated cells were used as a negative control. For treatments at 28&#x000ba;C, plates were incubated at this temperature for 24 h. Then, each well was diluted 1:10 with 10% formaldehyde in PBS and cells were counted in a hemocytometer. For treatment at 4&#x000ba;C, plates were incubated at this temperature for 24 h and then subjected to the MTT assay (see &#x0201c;MTT assay&#x0201d;). Due to the small size of trypomastigotes, the MTT reagent was used at the concentration of 1 mg/mL (2.5 fold less than that used for epimastigotes), which improved the correlation between the number of viable cells and the optical density (not shown). The major constituents of <italic>P. aduncum</italic> EO - linalool and nerolidol (both from Sigma, St. Louis, MO, USA) - were also tested (at the concentrations of 100, 250, 500 or 1000 ng/mL) against <italic>T. cruzi</italic> cell-derived trypomastigotes at 4&#x000ba;C, as described above.</p><p>To test <italic>Pa</italic>EO activity on metacyclic trypomastigotes, these cells were plated in 96-well plates (5 x 10<sup>6</sup> cells/well) with TAU3AAG medium, and treated with EO at the final concentrations of 1, 10, 50 or 100 &#x000b5;g/mL, for 24 h at 28&#x000ba;C. Then, each well was diluted at 1:10 with 10% formaldehyde in PBS, and cells were counted in a hemocytometer.</p><p>To test <italic>Pa</italic>EO activity against intracellular amastigotes, Vero cells were seeded in 24-well plates (2 x 10<sup>4</sup> cells/well) in DMEM (Sigma-Aldrich), and allowed to adhere for 24 h. Then, cell-derived trypomastigotes were added to each well (1:10 ratio of cells to parasites), incubated for 3 h, and non-internalised parasites were removed by washing with PBS. Infected cultures were incubated for 24 h (at 37&#x000ba;C, 5% CO<sub>2</sub>), and then the culture medium was replaced with RPMI-1640 containing <italic>Pa</italic>EO or BZ at final concentrations between 1 and 100 &#x000b5;g/mL (total volume of 1 mL/well), and plates were incubated for 24 h, at 37&#x000ba;C (5% CO<sub>2</sub>). Treated cells were fixed with methanol, stained with Giemsa, and the inhibitory effect on intracellular amastigotes was estimated by counting (a) the number of infected cells, and (b) the number of amastigotes per cell, in 100 cells/wells, from random light microscopy images. These data were used to calculate the infection index (II) for each tested concentration (II = % infected cells x number of amastigotes per cell).</p><p>
<italic>MTT assay</italic> - After drug treatments, MTT solution (10 mg/mL in PBS) was added to each well for a final concentration of 2.5 mg/mL (or 1 mg/mL for trypomastigotes). Plates were incubated for 3 h at 28&#x000ba;C in the dark, centrifuged for 10 min at 475 <italic>g</italic> and the supernatant was removed (by quick plate reversal). Then, 20 &#x000b5;L SDS was added to each well, followed by incubation for 1 h at 28&#x000ba;C, after which 80 &#x000b5;L DMSO was added to each well and incubated for a further 1 h at 28&#x000ba;C. Finally, the residual material was removed with the aid of a toothpick, and sample absorbance (at 550 nm) was read in an EL800 microplate reader (Biotek, Winooski, VT, USA). Dose-response curves were produced using the CompuSyn software, which was also used to calculate IC<sub>50</sub>/24 values.</p><p>
<italic>Cytotoxicity</italic> - Vero cells were seeded in 96-well plates (2 x 10<sup>4</sup> cells/well) with RPMI-1640 medium and cultivated for 24 h at 37&#x000ba;C (5% CO<sub>2</sub>). Cells were incubated for a further 24 h in the presence of <italic>Pa</italic>EO (9, 18, 37, 75, 150 or 300 &#x000b5;g/mL), linalool/nerolidol (30, 60, 125, 250 or 500 ng/mL), BZ (1, 10, 100 or 1000 &#x000b5;g/mL) or gentian violet (100, 500 or 1000 &#x000b5;g/mL). Then, plates were subjected to the MTT assay as described above (see &#x0201c;MTT assay&#x0201d;), and MTT data were used to calculate 50% cytotoxicity (CC<sub>50</sub>/24 h) values. Plates were examined in an inverted microscope every 12 h, to evaluate monolayer integrity (confluence and adhesion).</p><p>To analyse cytotoxicity on red blood cells (RBCs) at 4&#x000ba;C, human erythrocytes were obtained from 10-mL blood samples (O+), from a healthy volunteer donor, as previously described (<xref rid="B28" ref-type="bibr">Izumi et al. 2012</xref>). After collection, blood was defibrillated and then washed with a sterile &#x02018;saline-glucose&#x02019; solution (0.85% NaCl/5% glucose). The final pellet was diluted in saline-glucose and centrifuged for 5 min at 1400 <italic>g</italic>. The supernatant was discarded and the pellet of RBCs was diluted in saline-glucose, for a final concentration of 6%. Then, RBCs were seeded in 96-well plates (3% RBCs/well) and treated with EO (0.1, 0.2, 0.4, 0.8, 1.6 or 3.2 mg/mL), for 5 h, at 4&#x000ba;C. Negative control samples represented untreated RBCs diluted in saline-glucose. After treatment, plates were centrifuged at 1027 <italic>g</italic> for 2 min, and 100 &#x000b5;L of supernatant from each well were transferred to a new plate and analysed (at 550 nm) in an EL800 microplate reader (Biotek, Winooski, VT, USA).</p><p>Cytotoxicity (CC<sub>50</sub>) values were calculated using Excel, and selectivity index (SI) values were calculated as the ratio between the CC<sub>50</sub>/24 h (for Vero cells or RBCs) and IC<sub>50</sub>/24 h values.</p><p>
<italic>Flow cytometry</italic> - For flow cytometry analysis, epimastigotes were seeded into 96-well plates (5 x 10<sup>6</sup> cells/well) in LIT medium and treated with <italic>Pa</italic>EO at a concentration corresponding to the IC<sub>50</sub>/24 h, for 24 h. Negative control cells were kept untreated. Then, cells were washed twice in PBS (with centrifugation at 7000 <italic>g</italic> for 2 min) and transferred to plastic flow cytometry tubes (300 &#x000b5;L/tube).</p><p>To evaluate the effect of <italic>Pa</italic>EO on the <italic>T. cruzi</italic> cell cycle, 1 mL of 10 &#x000b5;g/mL propidium iodide diluted in 5% NP40, with 20 &#x000b5;g/mL RNAse (Qubit RNA HS Assay Kit, ThermoFisher Scientific, Waltham, MA, USA) was added to each tube, and samples were incubated for 20 min at 28&#x000ba;C.</p><p>To evaluate the effect of <italic>Pa</italic>EO on <italic>T. cruzi</italic> mitochondrial membrane potential, rhodamine 123 (final concentration 10 &#x000b5;g/mL) was added to cultures after <italic>Pa</italic>EO treatment, and cells were incubated for 20 min at 28&#x000ba;C, before PBS washing and transfer to flow cytometry tubes. Culture treatment with 10 &#x000b5;M CCCP (carbonyl cyanide 3-clorophenylhydrazone, Sigma Aldrich, St. Louis, MO, USA) after the rhodamine incubation was used as a positive control.</p><p>Flow cytometry samples were analysed in a FACS Canto II (Becton-Dickinson, San Jose, CA, USA) flow cytometer (20,000 events/sample; 488 nm excitation and 585/42 nm emission for propidium iodide; 488 excitation and 530/30 emission for rhodamine 123), and data analysis was performed in FlowJo (Treestar Software, Ashland, OR, USA). Statistical analysis was performed by one-way analysis of variance (ANOVA), using GraphPad Prism 5.01 software.</p></sec><sec sec-type="results"><title>RESULTS</title><p>
<italic>Cell-derived T. cruzi trypomastigotes are sensitive to PaEO</italic> - The EO of <italic>P. aduncum</italic> - a pepper species that has already yielded anti-trypanocidal extracts and molecules - had not been tested for its biological activity against <italic>T. cruzi</italic>. Thus, we tested the purified <italic>Pa</italic>EO against different <italic>T. cruzi</italic> developmental forms, namely epimastigotes (axenically grown insect forms), cell-derived amastigotes and trypomastigotes (produced in monolayers of mammalian host cells) and infective metacyclic trypomastigotes (differentiated, by metacyclogenesis in vitro, from epimastigotes) (<xref ref-type="fig" rid="f01">Fig. 1</xref>). As a reference drug, we used BZ, the current first-line for Chagas disease.</p><p>
<fig id="f01" orientation="portrait" position="float"><label>Fig. 1</label><caption><title>: effect of <italic>Piper aduncum</italic> essential oil (<italic>Pa</italic>EO) on <italic>Trypanosoma cruzi</italic>. Dose-response curves showing the inhibitory effect of <italic>Pa</italic>EO on <italic>T. cruzi</italic> metacyclic trypomastigotes (meta), cell-derived trypomastigotes (try) and intracellular amastigotes (ama). Fa = Fraction of affected cells (ratio to untreated control).</title></caption><graphic xlink:href="0074-0276-mioc-112-2-0131-gf01"/></fig>
</p><p>Cell-derived trypomastigotes were more sensitive to <italic>Pa</italic>EO (IC<sub>50</sub>/24 h at 28&#x000ba;C = 2.8 &#x000b5;g/mL) than to BZ (IC<sub>50</sub>/24 h = 16.1 &#x000b5;g/mL) (<xref ref-type="table" rid="t1">Table I</xref>). Metacyclic trypomastigotes were also sensitive to <italic>P. aduncum</italic> EO, with IC<sub>50</sub>/24 h values for <italic>Pa</italic>EO and BZ of 12.1 &#x000b5;g/mL and 0.3 &#x000b5;g/mL, respectively.</p><p>
<table-wrap id="t1" orientation="portrait" position="float"><label>TABLE I</label><caption><title>Inhibitory effect (IC50/24 h) and selectivity index (SI) of <italic>Piper aduncum</italic> essential oil (<italic>Pa</italic>EO) for the treatment of different <italic>Trypanosoma cruzi</italic> developmental forms, compared with benznidazole (BZ)</title></caption><table frame="hsides" rules="groups"><colgroup width="20%" span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><th align="left" rowspan="3" style="font-weight:normal" colspan="1">&#x000a0;</th><th colspan="2" style="font-weight:normal" rowspan="1">IC<sub>50</sub>/24 h (mg/mL)</th><th colspan="2" style="font-weight:normal" rowspan="1">Selectivity index (SI)</th></tr><tr><th colspan="4" rowspan="1" style="font-weight:normal">
<hr/>
</th></tr><tr><th style="font-weight:normal" rowspan="1" colspan="1">
<italic>Pa</italic>EO</th><th style="font-weight:normal" rowspan="1" colspan="1">BZ</th><th style="font-weight:normal" rowspan="1" colspan="1">
<italic>Pa</italic>EO<sup>a</sup>
</th><th style="font-weight:normal" rowspan="1" colspan="1">BZ<sup>b</sup>
</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Cell-derived trypomastigotes (28&#x000ba;C)</td><td align="center" rowspan="1" colspan="1">2.8</td><td align="center" rowspan="1" colspan="1">16.1</td><td align="center" rowspan="1" colspan="1">15.3</td><td align="center" rowspan="1" colspan="1">63.4</td></tr><tr><td rowspan="1" colspan="1">Cell-derived trypomastigotes (4&#x000ba;C)</td><td align="center" rowspan="1" colspan="1">3.8</td><td align="center" rowspan="1" colspan="1">ND</td><td align="center" rowspan="1" colspan="1">11.3</td><td align="center" rowspan="1" colspan="1">ND</td></tr><tr><td rowspan="1" colspan="1">Metacyclic trypomastigotes (28&#x000ba;C)</td><td align="center" rowspan="1" colspan="1">12.1</td><td align="center" rowspan="1" colspan="1">0.3</td><td align="center" rowspan="1" colspan="1">3.5</td><td align="center" rowspan="1" colspan="1">3,646.4</td></tr><tr><td rowspan="1" colspan="1">Epimastigotes (28&#x000ba;C)</td><td align="center" rowspan="1" colspan="1">84.7</td><td align="center" rowspan="1" colspan="1">14.7</td><td align="center" rowspan="1" colspan="1">0.5</td><td align="center" rowspan="1" colspan="1">69.4</td></tr><tr><td rowspan="1" colspan="1">Amastigotes (37&#x000ba;C)</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">0.8</td><td align="center" rowspan="1" colspan="1">4.7</td><td align="center" rowspan="1" colspan="1">1,276.2</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p>
<italic>a</italic>: SI = CC<sub>50</sub>
<italic>Pa</italic>EO on Vero cells (42.8 &#x000b5;g/mL) / IC<sub>50</sub>
<italic>Pa</italic>EO; <italic>b</italic>: SI = CC<sub>50</sub> BZ on Vero cells (1021 &#x000b5;g/mL) / IC<sub>50</sub> BZ; ND: not done.</p></fn></table-wrap-foot></table-wrap>
</p><p>
<italic>T. cruzi</italic> epimastigotes were incubated for 24 h at 28&#x000ba;C with different concentrations of <italic>Pa</italic>EO or BZ, and dose-response curves estimated the IC<sub>50</sub>/24 h values as 84.7 &#x000b5;g/mL for <italic>Pa</italic>EO and 14.7 &#x000b5;g/mL (45 &#x000b5;M) for BZ (<xref ref-type="table" rid="t1">Table I</xref>).</p><p>Blood transfusion is an important route for Chagas disease transmission, due to the presence of infective trypomastigotes in blood from infected donors. Thus, we tested the sensitivity of cell-derived trypomastigotes to <italic>Pa</italic>EO at 4&#x000ba;C, the temperature used for red blood storage in blood banks. Incubation at 4&#x000ba;C led to inactivation of BZ, as evidenced by the presence of clumps of crystalline material in the medium (likely representing BZ agglutination), and by the absence of trypanosome morphological damage or motility loss, as assessed by light microscopy observation (not shown). Therefore, for the experiments at 4&#x000ba;C we used gentian violet as a control, since this drug can be used to treat blood potentially infected with Chagas disease (<xref rid="B40" ref-type="bibr">Ramirez et al. 1995</xref>). Importantly, cell-derived trypomastigotes were 6,500 times more sensitive to <italic>P. aduncum</italic> EO (IC<sub>50</sub>/24 h = 3.8 &#x000b5;g/mL) than to gentian violet (IC<sub>50</sub>/24 h = 24,700 mg/mL).</p><p>To estimate <italic>Pa</italic>EO cytotoxicity, we performed cytotoxicity assays in uninfected Vero cells at 37&#x000ba;C (<xref ref-type="table" rid="t2">Table II</xref>), and also in human erythrocytes (RBCs) at 4&#x000ba;C (to mimic red blood cell storage conditions in blood banks). <italic>Pa</italic>EO was more cytotoxic to Vero cells than BZ, with a CC<sub>50</sub>/24 h of 42.8 &#x000b5;g/mL, compared with 1,021 mg/mL for BZ. At the treatment temperature of 4&#x000ba;C, gentian violet also exhibited lower cytotoxicity to RBCs (CC<sub>50</sub>/24 h = 71.4 mg/mL) than <italic>Pa</italic>EO (CC<sub>5</sub>/24 h = 351.6 &#x000b5;g/mL).</p><p>
<table-wrap id="t2" orientation="portrait" position="float"><label>TABLE II</label><caption><title>Inhibitory effect (IC50/24 h, in &#x000b5;g/mL) and cytotoxicity (CC50/24 h, in &#x000b5;g/mL) of <italic>Piper aduncum</italic> essential oil (<italic>Pa</italic>EO), gentian violet and linalool for <italic>Trypanosoma cruzi</italic> cell-derived trypomastigotes, red blood cells (RBCs, at 4&#x000ba;C) and Vero cells (at 37&#x000ba;C)</title></caption><table frame="hsides" rules="groups"><colgroup width="17%" span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><th align="left" style="font-weight:normal" rowspan="1" colspan="1">&#x000a0;</th><th style="font-weight:normal" rowspan="1" colspan="1">
<italic>T. cruzi</italic> IC<sub>50</sub>/24 h</th><th style="font-weight:normal" rowspan="1" colspan="1">RBCs CC<sub>50</sub>/24 h</th><th style="font-weight:normal" rowspan="1" colspan="1">Selectivity index (SI) - RBCs</th><th style="font-weight:normal" rowspan="1" colspan="1">Vero cells CC<sub>50</sub>/24 h</th><th style="font-weight:normal" rowspan="1" colspan="1">Selectivity index (SI) - Vero cells</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">
<italic>Pa</italic>EO</td><td align="center" rowspan="1" colspan="1">3.8</td><td align="center" rowspan="1" colspan="1">351.6</td><td align="center" rowspan="1" colspan="1">92.5</td><td align="center" rowspan="1" colspan="1">42.8</td><td align="center" rowspan="1" colspan="1">11.2</td></tr><tr><td rowspan="1" colspan="1">Linalool</td><td align="center" rowspan="1" colspan="1">0.31</td><td align="center" rowspan="1" colspan="1">7,341.6</td><td align="center" rowspan="1" colspan="1">23,990</td><td align="center" rowspan="1" colspan="1">0.87</td><td align="center" rowspan="1" colspan="1">2.7</td></tr><tr><td rowspan="1" colspan="1">Gentian Violet</td><td align="center" rowspan="1" colspan="1">24,700</td><td align="center" rowspan="1" colspan="1">&#x0003e; 70,000</td><td align="center" rowspan="1" colspan="1">&#x0003e; 2.8</td><td align="center" rowspan="1" colspan="1">71,400</td><td align="center" rowspan="1" colspan="1">2.9</td></tr></tbody></table></table-wrap>
</p><p>Selectivity index (SI) analysis - representing the ratio between IC<sub>50</sub>/24 h and CC<sub>50</sub>/24 h values - indicates that <italic>Pa</italic>EO is particularly selective towards cell-derived <italic>T. cruzi</italic> trypomastigotes (SI = 15.3 and 11.3, for treatments with Vero cells at 28&#x000ba;C and 4&#x000ba;C, respectively; <xref ref-type="table" rid="t1">Table I</xref>). Importantly, at the treatment temperature of 4&#x000ba;C, <italic>Pa</italic>EO was more selective towards this form of the parasite than gentian violet (SI = 2.9).</p><p>
<italic>PaEO inhibits effectively the intracellular survival/replication of T. cruzi amastigotes</italic> - To test the effect of <italic>Pa</italic>EO on amastigotes, Vero cells were infected with trypomastigotes and, after 24 h (when trypomastigotes had differentiated into amastigotes), the infected cultures were incubated with different concentrations of <italic>Pa</italic>EO (or BZ, as a reference). <italic>Pa</italic>EO at the concentration of 12.5 &#x000b5;g/mL decreased the <italic>T. cruzi</italic> amastigote infection index by 71.5%, similarly to 10 &#x000b5;g/mL BZ (81.3% decrease; <xref ref-type="table" rid="t3">Table III</xref>), showing that <italic>Pa</italic>EO is as effective as the standard drug used for Chagas disease treatment, at this concentration. However, BZ was much more efficient than <italic>Pa</italic>EO at inhibiting intracellular amastigote replication and survival, with an IC<sub>50</sub>/24 h (calculated from infection index data) of 0.8 &#x000b5;g/mL, compared with 9 &#x000b5;g/mL for <italic>Pa</italic>EO (<xref ref-type="table" rid="t1">Table I</xref>). Also, strong cytotoxic effects occurred after treatment with 100 &#x000b5;g/mL <italic>Pa</italic>EO (data not shown).</p><p>
<table-wrap id="t3" orientation="portrait" position="float"><label>TABLE III</label><caption><title>Effect of 24 h-treatment with <italic>Piper aduncum</italic> essential oil (<italic>Pa</italic>EO) on <italic>Trypanosoma cruzi</italic> intracellular amastigotes in Vero cells, compared with benznidazole (BZ)</title></caption><table frame="hsides" rules="groups"><colgroup width="17%" span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><th align="left" style="font-weight:normal" rowspan="1" colspan="1">&#x000a0;</th><th style="font-weight:normal" rowspan="1" colspan="1">Concentration (&#x000b5;g/mL)</th><th style="font-weight:normal" rowspan="1" colspan="1">Infected cells (%)</th><th style="font-weight:normal" rowspan="1" colspan="1">Amastigotes per cell</th><th style="font-weight:normal" rowspan="1" colspan="1">Infection index (II)</th><th style="font-weight:normal" rowspan="1" colspan="1">II decrease</th></tr></thead><tbody><tr><td rowspan="4" colspan="1">
<italic>Pa</italic>EO</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">79.1</td><td align="center" rowspan="1" colspan="1">7.1</td><td align="center" rowspan="1" colspan="1">562.1</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="center" rowspan="1" colspan="1">12.5</td><td align="center" rowspan="1" colspan="1">54.6</td><td align="center" rowspan="1" colspan="1">2.9</td><td align="center" rowspan="1" colspan="1">160.1</td><td align="center" rowspan="1" colspan="1">71.5</td></tr><tr><td align="center" rowspan="1" colspan="1">50</td><td align="center" rowspan="1" colspan="1">32.5</td><td align="center" rowspan="1" colspan="1">0.4</td><td align="center" rowspan="1" colspan="1">12.7</td><td align="center" rowspan="1" colspan="1">97.7</td></tr><tr><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">100</td></tr><tr><td rowspan="3" colspan="1">BZ</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">87.3</td><td align="center" rowspan="1" colspan="1">11.5</td><td align="center" rowspan="1" colspan="1">1003.7</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">74.9</td><td align="center" rowspan="1" colspan="1">2.5</td><td align="center" rowspan="1" colspan="1">187.2</td><td align="center" rowspan="1" colspan="1">81.3</td></tr><tr><td align="center" rowspan="1" colspan="1">50</td><td align="center" rowspan="1" colspan="1">0.4</td><td align="center" rowspan="1" colspan="1">0.9</td><td align="center" rowspan="1" colspan="1">0.3</td><td align="center" rowspan="1" colspan="1">99.9</td></tr></tbody></table></table-wrap>
</p><p>To examine the mechanism of action of <italic>Pa</italic>EO on <italic>T. cruzi</italic>, epimastigotes were incubated for 24 h at 28&#x000ba;C with the EO and then subjected to cell cycle analysis by labeling with propidium iodide, or were labelled with Rhodamine-123, to analyse the effect of <italic>Pa</italic>EO on the mitochondrial membrane potential. Although epimastigotes do not have direct medical importance, this life cycle form is ideal for in vitro analysis, because they can be cultivated easily in axenic medium.</p><p>Treatment of epimastigotes with <italic>P</italic>aEO at the IC<sub>50</sub>/24 h did not alter significantly the number of cells in the G1 phase of the cell cycle, but there was a significant decrease in the number of cells in G2 (<xref ref-type="fig" rid="f02">Fig. 2A-B</xref>). Labeling with rhodamine-123 showed that the <italic>Pa</italic>EO decreased the mitochondrial membrane potential of nearly 98% of the tested epimastigotes (<xref ref-type="fig" rid="f02">Fig. 2C-D</xref>), indicating a possible target of this compound.</p><p>
<fig id="f02" orientation="portrait" position="float"><label>Fig. 2</label><caption><title>: effect of <italic>Piper aduncum</italic> essential oil (<italic>Pa</italic>EO) on <italic>Trypanosoma cruzi</italic> epimastigotes, as analysed by flow cytometry. (A-B) Cell cycle analysis. Epimastigotes were treated for 24 h at 28&#x000b0;C with the IC50/24 h value of <italic>Pa</italic>EO and then incubated with propidium iodide (PI). (A) Histograms of the PI-stained cell populations; (B) mean number of cells in each cell cycle stage. *: p &#x0003c; 0.05. (C-D) Mitochondrial membrane potential analysis. Epimastigotes were kept for 24 h at 28&#x000b0;C with the IC50/2 h value of <italic>Pa</italic>EO and then incubated with Rhodamine-123. CCCP (carbonyl cyanide 3-clorophenylhydrazone): positive control. (C) Histograms of the Rhodamine-123-stained populations; (D) percentage of labelled cells after each treatment.</title></caption><graphic xlink:href="0074-0276-mioc-112-2-0131-gf02"/></fig>
</p><p>Chemical composition analysis by gas chromatography/mass spectrometry (GC-MS) showed that the main constituents of the <italic>Pa</italic>EO used in this study are nerolidol (25.22%) and linalool (13.42%) (<xref ref-type="table" rid="t4">Table IV</xref>). Aside from these two main constituents, <italic>Pa</italic>EO contained several minor components (each accounting for ~1-5% of the total area; <xref ref-type="table" rid="t4">Table IV</xref>). Therefore, we tested the activities of linalool and nerolidol against cell-derived trypomastigotes at 4&#x000ba;C (for 24 h), because the activity of <italic>Pa</italic>EO against this developmental form appeared to be particularly promising (<xref ref-type="table" rid="t1">Table I</xref>). Linalool had clear trypanocidal activity, with an IC<sub>50</sub>/24 h of 306 ng/mL at 4&#x000ba;C (<xref ref-type="table" rid="t2">Table II</xref>), indicating that this compound is approximately 52 times more effective against cell-derived trypanosomes than BZ at 28&#x000ba;C (<xref ref-type="table" rid="t1">Table I</xref>). Cytotoxicity tests on Vero cells (at 4&#x000ba;C) demonstrated that linalool was cytotoxic, however, with a CC<sub>50</sub>/24 h of 823.6 ng/mL, which resulted in a selectivity index (SI) for the treatment of cell-derived trypomastigotes at 4&#x000ba;C of 2.69 (<xref ref-type="table" rid="t2">Table II</xref>).</p><p>
<table-wrap id="t4" orientation="portrait" position="float"><label>TABLE IV</label><caption><title>Chemical composition of <italic>Piper aduncum</italic> essential oil (<italic>Pa</italic>EO), as assessed by gas chromatography/mass spectrometry (GC/MS)</title></caption><table frame="hsides" rules="groups"><colgroup width="25%" span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><th align="left" style="font-weight:normal" rowspan="1" colspan="1">Constituent</th><th style="font-weight:normal" rowspan="1" colspan="1">Retention time</th><th style="font-weight:normal" rowspan="1" colspan="1">Area</th><th style="font-weight:normal" rowspan="1" colspan="1">Area (%)</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Nerolidol</td><td align="center" rowspan="1" colspan="1">31.13</td><td align="center" rowspan="1" colspan="1">18000000</td><td align="center" rowspan="1" colspan="1">25.22</td></tr><tr><td rowspan="1" colspan="1">Linalool</td><td align="center" rowspan="1" colspan="1">11.83</td><td align="center" rowspan="1" colspan="1">9336350</td><td align="center" rowspan="1" colspan="1">13.42</td></tr><tr><td rowspan="1" colspan="1">Spatulenol</td><td align="center" rowspan="1" colspan="1">31.77</td><td align="center" rowspan="1" colspan="1">4374871</td><td align="center" rowspan="1" colspan="1">6.29</td></tr><tr><td rowspan="1" colspan="1">&#x003b2;-ocimene</td><td align="center" rowspan="1" colspan="1">9.76</td><td align="center" rowspan="1" colspan="1">3237239</td><td align="center" rowspan="1" colspan="1">4.65</td></tr><tr><td rowspan="1" colspan="1">2-cycloexen-1-ol</td><td align="center" rowspan="1" colspan="1">25.48</td><td align="center" rowspan="1" colspan="1">3092676</td><td align="center" rowspan="1" colspan="1">4.44</td></tr><tr><td rowspan="1" colspan="1">Germacrene D</td><td align="center" rowspan="1" colspan="1">27.99</td><td align="center" rowspan="1" colspan="1">2804545</td><td align="center" rowspan="1" colspan="1">4.03</td></tr><tr><td rowspan="1" colspan="1">&#x003b2;-chamigrene</td><td align="center" rowspan="1" colspan="1">28.59</td><td align="center" rowspan="1" colspan="1">2788502</td><td align="center" rowspan="1" colspan="1">4.01</td></tr><tr><td rowspan="1" colspan="1">E-&#x003b2;-farnesene</td><td align="center" rowspan="1" colspan="1">26.95</td><td align="center" rowspan="1" colspan="1">2509366</td><td align="center" rowspan="1" colspan="1">3.61</td></tr><tr><td rowspan="1" colspan="1">&#x003b3;-cadinene</td><td align="center" rowspan="1" colspan="1">29.37</td><td align="center" rowspan="1" colspan="1">2439762</td><td align="center" rowspan="1" colspan="1">3.51</td></tr><tr><td rowspan="1" colspan="1">&#x003b1;-epi-muurolol</td><td align="center" rowspan="1" colspan="1">34.25</td><td align="center" rowspan="1" colspan="1">1893537</td><td align="center" rowspan="1" colspan="1">2.72</td></tr><tr><td rowspan="1" colspan="1">&#x003b1;-bisabolol oxide</td><td align="center" rowspan="1" colspan="1">34.75</td><td align="center" rowspan="1" colspan="1">1867181</td><td align="center" rowspan="1" colspan="1">2.68</td></tr><tr><td rowspan="1" colspan="1">&#x003b1;-ocimene</td><td align="center" rowspan="1" colspan="1">9.36</td><td align="center" rowspan="1" colspan="1">1807180</td><td align="center" rowspan="1" colspan="1">2.6</td></tr><tr><td rowspan="1" colspan="1">Turmerone</td><td align="center" rowspan="1" colspan="1">32.49</td><td align="center" rowspan="1" colspan="1">1437434</td><td align="center" rowspan="1" colspan="1">2.07</td></tr><tr><td rowspan="1" colspan="1">Caryophyllene oxide</td><td align="center" rowspan="1" colspan="1">31.98</td><td align="center" rowspan="1" colspan="1">1248458</td><td align="center" rowspan="1" colspan="1">1.79</td></tr><tr><td rowspan="1" colspan="1">&#x003b1;-copaene</td><td align="center" rowspan="1" colspan="1">23.65</td><td align="center" rowspan="1" colspan="1">1169184</td><td align="center" rowspan="1" colspan="1">1.68</td></tr><tr><td rowspan="1" colspan="1">Viridiflorol</td><td align="center" rowspan="1" colspan="1">33.04</td><td align="center" rowspan="1" colspan="1">1117593</td><td align="center" rowspan="1" colspan="1">1.61</td></tr><tr><td rowspan="1" colspan="1">&#x003b2;-pinene</td><td align="center" rowspan="1" colspan="1">7.5</td><td align="center" rowspan="1" colspan="1">988059</td><td align="center" rowspan="1" colspan="1">1.42</td></tr><tr><td rowspan="1" colspan="1">&#x003b1;-cadinol</td><td align="center" rowspan="1" colspan="1">34.43</td><td align="center" rowspan="1" colspan="1">975559</td><td align="center" rowspan="1" colspan="1">1.4</td></tr><tr><td rowspan="1" colspan="1">&#x003b1;-cubebene</td><td align="center" rowspan="1" colspan="1">24.16</td><td align="center" rowspan="1" colspan="1">884691</td><td align="center" rowspan="1" colspan="1">1.27</td></tr><tr><td rowspan="1" colspan="1">&#x003b4;-cadineme</td><td align="center" rowspan="1" colspan="1">29.5</td><td align="center" rowspan="1" colspan="1">854201</td><td align="center" rowspan="1" colspan="1">1.23</td></tr><tr><td rowspan="1" colspan="1">&#x003b1;-pinene</td><td align="center" rowspan="1" colspan="1">6.2</td><td align="center" rowspan="1" colspan="1">680357</td><td align="center" rowspan="1" colspan="1">0.98</td></tr><tr><td rowspan="1" colspan="1">Safrole</td><td align="center" rowspan="1" colspan="1">19.94</td><td align="center" rowspan="1" colspan="1">640257</td><td align="center" rowspan="1" colspan="1">0.92</td></tr></tbody></table></table-wrap>
</p><p>In contrast to linalool, nerolidol had no appreciable trypanocidal activity against cell-derived trypomastigotes (4&#x000ba;C, 24 h) at concentrations between 100 ng/mL and 1 &#x000b5;g/mL, as assessed by light microscopy observation and MTT assays (data not shown). Also, nerolidol did not affect the integrity of Vero cell monolayers, after treatment for 24 h with the highest concentration used (1 &#x000b5;g/mL; not shown). These data indicate that the trypanocidal effect of <italic>Pa</italic>EO was due to linalool.</p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>The microbicidal activity of EOs - against fungi, bacteria and viruses - is used primarily as a defense to ensure plant survival (<xref rid="B7" ref-type="bibr">Bakkali et al. 2008</xref>). A number of EOs are active against <italic>T. cruzi</italic> epimastigotes and trypomastigotes (<xref rid="B46" ref-type="bibr">Santoro et al. 2007a</xref>, <xref rid="B47" ref-type="bibr">b</xref>, <xref rid="B17" ref-type="bibr">Escobar et al. 2010</xref>, <xref rid="B10" ref-type="bibr">Borges et al. 2012</xref>, <xref rid="B50" ref-type="bibr">Silva et al. 2013</xref>, <xref rid="B6" ref-type="bibr">Azeredo et al. 2014</xref>) and recent studies showed that EOs from different pepper species (<italic>Piper</italic> spp.) have promising leishmanicidal (<xref rid="B34" ref-type="bibr">Monzote et al. 2010</xref>) and trypanocidal (<xref rid="B18" ref-type="bibr">Esperandim et al. 2013</xref>) activities. Nevertheless, the EO of the pepper species <italic>P. aduncum</italic> - whose extracts have clear trypanocidal activity - had not been tested previously against <italic>T. cruzi</italic>.</p><p>In the present study, we show that <italic>T. cruzi</italic> trypomastigotes and amastigotes are sensitive to <italic>Pa</italic>EO at concentrations of 2.8 to 12.1 &#x000b5;g/mL (<xref ref-type="table" rid="t1">Table I</xref>). Importantly, the highly infective cell-derived trypomastigote forms - which can be found in contaminated blood from Chagas disease patients - were particularly sensitive to <italic>Pa</italic>EO, with an IC<sub>50</sub>/24 h of 2.8 &#x000b5;g/mL.</p><p>Also, treatment of <italic>T. cruzi</italic> trypomastigotes and human erythrocytes with <italic>Pa</italic>EO at 4&#x000ba;C resulted in an excellent selectivity index (SI = 92.5) (<xref ref-type="table" rid="t2">Table II</xref>). The first desirable property of a promising drug candidate is an SI &#x0003e; 50 (<xref rid="B44" ref-type="bibr">Romanha et al. 2010</xref>); thus, <italic>P</italic>aEO (or its main constituent linalool) is a promising alternative for further testing on blood/blood cells, under thermal conditions of red blood cells storage (4&#x000ba;C), in order to obtain derivatives effective at eliminating <italic>T. cruzi</italic> in blood bank samples.</p><p>In our tests with cell-derived trypomastigotes at 4&#x000ba;C the use of BZ for 24 h had no effect against the parasite (not shown). The incomplete trypanocidal effect of BZ at 4&#x000ba;C can lead to Chagas disease transmission via transfusion of contaminated blood (<xref rid="B33" ref-type="bibr">Martin et al. 2014</xref>). Gentian violet was the reference drug of choice in our tests at 4&#x000ba;C, because it can be used to control <italic>T. cruzi</italic> infection in blood banks (<xref rid="B40" ref-type="bibr">Ramirez et al. 1995</xref>). However, the prophylaxis alternative with gentian violet produces side effects, such as staining in the mucosa and erythrocyte agglutination (<xref rid="B16" ref-type="bibr">Docampo &#x00026; Moreno 1990</xref>).</p><p>In this study, most testing was performed for 24 h, to minimise the effects of nutrient starvation and toxicity due to parasite lysis. We believe that these conditions are closer to those found in the mammalian host, where toxin waste is eliminated through the bloodstream. Our data with BZ differ from that reported in other studies, where this drug was often tested for 72 h, yielding lower IC<sub>50</sub> values (<xref rid="B21" ref-type="bibr">Franklim et al. 2013</xref>, <xref rid="B24" ref-type="bibr">Hamedt et al. 2014</xref>). To date, no standard conditions for drug testing against <italic>T. cruzi</italic> have been defined. Therefore, differences in parasite strains, incubation times and temperatures and culture media may all account for variations observed in experimental drug testing, and are likely to delay drug development for Chagas disease treatment (<xref rid="B4" ref-type="bibr">Andrade et al. 1985</xref>).</p><p>Mitochondrial membrane potential evaluation of epimastigotes by flow cytometry demonstrated that <italic>Pa</italic>EO decreased the mitochondrial membrane potential of ~98% of the treated cells, with similar results obtained with the positive control with CCCP. Therefore, <italic>Pa</italic>EO may be acting on the parasite mitochondrion. Accordingly, it has been already shown that other natural products induce depolarisation of mitochondrial membrane in Trypanosomatids such as <italic>T. cru</italic>zi and <italic>Leishmania</italic> (<xref rid="B27" ref-type="bibr">Inacio et al. 2012</xref>, <xref rid="B11" ref-type="bibr">Caleare et al. 2013</xref>, <xref rid="B43" ref-type="bibr">Ribeiro et al. 2013</xref>, <xref rid="B52" ref-type="bibr">Takahashi et al. 2013</xref>, <xref rid="B1" ref-type="bibr">Alian&#x000e7;a et al. 2014</xref>, <xref rid="B13" ref-type="bibr">Corpas-L&#x000f3;pez et al. 2016</xref>, <xref rid="B51" ref-type="bibr">S&#x000fc;lsen et al. 2016</xref>).</p><p>EOs may affect different cellular targets, due to variations in their molecular composition. As they contain lipophilic molecules, the mechanism of action of EOs involves breakage and/or crossing of the plasma membrane (<xref rid="B30" ref-type="bibr">Knobloch et al. 1989</xref>, <xref rid="B49" ref-type="bibr">Sikkema et al. 1994</xref>). While our data showed that the <italic>Pa</italic>EO may target the mitochondrion, we can not exclude the possibility that mitochondrial damage is a secondary effect of drug treatment.</p><p>The <italic>Pa</italic>EO used in this work had nerolidol (25.22%) and linalool (13.42%) as its main constituents. GC-MS analysis of the essential oil of <italic>P. aduncum</italic> in other studies showed that it can yield four major constituents: (a) dillapiole, at 79.9-86.9% (<xref rid="B2" ref-type="bibr">Almeida et al. 2009</xref>); (b) nerolidol, at 79.2-82.5% (<xref rid="B37" ref-type="bibr">Oliveira et al. 2006</xref>); (c) cineole, at 54% (<xref rid="B36" ref-type="bibr">Oliveira et al. 2013</xref>), and (d) linalool, at 31-41% (<xref rid="B35" ref-type="bibr">Navickiene et al. 2006</xref>). This variation in composition may be explained by the collection of plants from different regions, and which are exposed to different environmental factors. Thus, to minimise EO composition variation between studies, the collected material should always come from the same location. The best thermal storage conditions for <italic>P. aduncum</italic> EO is 20&#x000ba;C (for up to six months), without loss of regenerative capacity (da <xref rid="B15" ref-type="bibr">Silva &#x00026; Scherwinski-Pereira 2011</xref>).</p><p>In this work we show that nerolidol - the major <italic>Pa</italic>EO component - failed to affect significantly the cell-derived trypomastigote form of <italic>T. cruzi</italic>, at 4&#x000ba;C, even at the concentration of 1 &#x000b5;g/mL. In contrast, linalool had potent trypanocidal effect against this parasite form, with an IC<sub>50</sub>/24 h of 306 ng/mL. These results show that the major component of an EO may not always be responsible for the lytic activity. Interestingly, incubation of linalool with <italic>T. cruzi</italic> blood trypomastigotes (Y strain) resulted in an IC<sub>50</sub>/24 h value of 264 &#x000b5;g/mL (<xref rid="B47" ref-type="bibr">Santoro et al. 2007b</xref>), indicating that trypomastigote forms of different origin (blood, cell culture or in vitro differentiation) and from different strains may differ in their susceptibility to EO derivatives.</p><p>Our cytotoxicity tests in Vero cells showed that cell monolayers remained intact after nerolidol treatment, without clear changes or toxic effects, even at the concentration of 1 &#x000b5;g/mL. However, linalool was cytotoxic, with CC<sub>50</sub>/24 of 823.6 ng/mL, indicating that the major constituent is not necessarily the one responsible for EO toxicity towards mammalian cells, as suggested in other studies (<xref rid="B2" ref-type="bibr">Almeida et al. 2009</xref>, <xref rid="B36" ref-type="bibr">Oliveira et al. 2013</xref>, <xref rid="B31" ref-type="bibr">Liu et al. 2014</xref>). Also, linalool was approximately 80,000 times more efficient against cell-derived trypomastigotes at 4&#x000ba;C than gentian violet, the drug commonly used to treat possibly contaminated blood bags.</p><p>In conclusion, our data indicate that the <italic>P. aduncum</italic> essential oil component linalool is a promising compound for further studies on the trypanocidal treatment of red blood cell bags at 4&#x000ba;C prior to transfusion, to prevent <italic>T. cruzi</italic> transmission via this important route. To improve the safety profile of linalool, combinations with less toxic compounds (including benznidazole) should be tested, and linalool could be used as a lead for further drug development.</p></sec></body><back><ack><title>ACKNOWLEDGEMENTS</title><p>To the Microscopy Center of the Federal University of Paran&#x000e1; (Curitiba, PR, Brazil) and the Rudolph Barth Electron Microscopy Platform of the Oswaldo Cruz Institute/Fiocruz, RJ, Brazil, for use of their electron microscopy facilities.</p></ack><fn-group><fn fn-type="financial-disclosure" id="fn2"><p>Financial support: CNPq, FAPEMIG, Fiocruz. LHV had a scholarship from the Students Program/Post-Graduation Agreement PEC-PG from CAPES/CNPq, Brazil.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="B1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alian&#x000e7;a</surname><given-names>ASS</given-names></name><name><surname>Anjos</surname><given-names>KF</given-names></name><name><surname>Reis</surname><given-names>TNV</given-names></name><name><surname>Higino</surname><given-names>TM</given-names></name><name><surname>Brelaz-de-Castro</surname><given-names>MC</given-names></name><name><surname>Bianco</surname><given-names>&#x000c9;M</given-names></name><etal>et al</etal></person-group><article-title>The in vitro biological activity of the Brazilian brown seaweed Dictyota mertensii against Leishmania amazonensis</article-title><source>Molecules</source><year>2014</year><volume>19</volume><issue>9</issue><fpage>14052</fpage><lpage>14065</lpage><pub-id pub-id-type="pmid">25207712</pub-id></element-citation></ref><ref id="B2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almeida</surname><given-names>RR</given-names></name><name><surname>Souto</surname><given-names>RN</given-names></name><name><surname>Bastos</surname><given-names>CN</given-names></name><name><surname>Silva</surname><given-names>MH</given-names></name><name><surname>Maia</surname><given-names>JG</given-names></name></person-group><article-title>Chemical variation in Piper aduncum and biological properties of its dillapiole-rich essential oil</article-title><source>Chem Biodivers</source><year>2009</year><volume>6</volume><issue>9</issue><fpage>1427</fpage><lpage>1434</lpage><pub-id pub-id-type="pmid">19774604</pub-id></element-citation></ref><ref id="B3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alviano</surname><given-names>DS</given-names></name><name><surname>Barreto</surname><given-names>AL</given-names></name><name><surname>Dias</surname><given-names>FA</given-names></name><name><surname>Rodrigues</surname><given-names>IA</given-names></name><name><surname>Rosa</surname><given-names>MS</given-names></name><name><surname>Alviano</surname><given-names>CS</given-names></name><etal>et al</etal></person-group><article-title>Conventional therapy and promising plant-derived compounds against trypanosomatid parasites</article-title><source>Front Microbiol</source><year>2012</year><volume>3</volume><size units="pages">283</size></element-citation></ref><ref id="B4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrade</surname><given-names>V</given-names></name><name><surname>Andrade</surname><given-names>SG</given-names></name><name><surname>Barrai</surname><given-names>M</given-names><suffix>Netto</suffix></name><name><surname>Pontes</surname><given-names>AL</given-names></name><name><surname>Castro</surname><given-names>R</given-names></name></person-group><article-title>Avalia&#x000e7;&#x000e3;o do comportamento de diferentes cepas do Trypanosoma cruzi na infec&#x000e7;&#x000e3;o de seis linhagens isog&#x000ea;nicas de camundongos</article-title><source>Rev Soc Bras Med Trop</source><year>1985</year><volume>18</volume><issue>3</issue><fpage>143</fpage><lpage>154</lpage></element-citation></ref><ref id="B5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Assal</surname><given-names>A</given-names></name><name><surname>Corbi</surname><given-names>C</given-names></name></person-group><article-title>Maladie de Chagas et transfusi&#x000f3;n sanguine: un probl&#x000e8;me parasitaire &#x000e9;mergent dans les pays non end&#x000e9;miques</article-title><source>Transfus Clin Biol</source><year>2011</year><volume>18</volume><fpage>286</fpage><lpage>291</lpage><pub-id pub-id-type="pmid">21440479</pub-id></element-citation></ref><ref id="B6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azeredo</surname><given-names>CMO</given-names></name><name><surname>Santos</surname><given-names>TG</given-names></name><name><surname>Maia</surname><given-names>BHLNS</given-names></name><name><surname>Soares</surname><given-names>MJ</given-names></name></person-group><article-title>In vitro biological evaluation of eight different essential oils against Trypanosoma cruzi, with emphasis on Cinnamomum verum essential oil</article-title><source>BMC Complement Altern Med</source><year>2014</year><volume>14</volume><size units="pages">309</size></element-citation></ref><ref id="B7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bakkali</surname><given-names>F</given-names></name><name><surname>Averbeck</surname><given-names>S</given-names></name><name><surname>Averbeck</surname><given-names>D</given-names></name><name><surname>Idaomar</surname><given-names>M</given-names></name></person-group><article-title>Biological effects of essential oils-a review</article-title><source>Food Chem Toxicol</source><year>2008</year><volume>46</volume><issue>2</issue><fpage>446</fpage><lpage>475</lpage><pub-id pub-id-type="pmid">17996351</pub-id></element-citation></ref><ref id="B8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Batista</surname><given-names>JM</given-names><suffix>Jr</suffix></name><name><surname>Lopes</surname><given-names>AA</given-names></name><name><surname>Ambr&#x000f3;sio</surname><given-names>DL</given-names></name><name><surname>Regasini</surname><given-names>LO</given-names></name><name><surname>Kato</surname><given-names>MJ</given-names></name><name><surname>Bolzani</surname><given-names>VS</given-names></name><etal>et al</etal></person-group><article-title>Natural chromenes and chromene derivatives as potential anti-trypanosomal agents</article-title><source>Biol Pharmac Bull</source><year>2008</year><volume>31</volume><issue>3</issue><fpage>538</fpage><lpage>540</lpage></element-citation></ref><ref id="B9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bern</surname><given-names>C</given-names></name></person-group><article-title>Antitrypanosomal therapy for chronic Chagas&#x02019; disease</article-title><source>N Engl J Med</source><year>2011</year><volume>364</volume><issue>26</issue><fpage>2527</fpage><lpage>2534</lpage><pub-id pub-id-type="pmid">21714649</pub-id></element-citation></ref><ref id="B10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borges</surname><given-names>AR</given-names></name><name><surname>Aires</surname><given-names>JR</given-names></name><name><surname>Higino</surname><given-names>TM</given-names></name><name><surname>Medeiros</surname><given-names>MGF</given-names></name><name><surname>Cit&#x000f3;</surname><given-names>AM</given-names></name><name><surname>Lopes</surname><given-names>JA</given-names></name><etal>et al</etal></person-group><article-title>Trypanocidal and cytotoxic activities of essential oils from medicinal plants of Northeast of Brazil</article-title><source>Exp Parasitol</source><year>2012</year><volume>132</volume><issue>2</issue><fpage>123</fpage><lpage>128</lpage><pub-id pub-id-type="pmid">22771867</pub-id></element-citation></ref><ref id="B11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caleare</surname><given-names>AO</given-names></name><name><surname>Lazarin-Bid&#x000f3;ia</surname><given-names>D</given-names></name><name><surname>Cortez</surname><given-names>DA</given-names></name><name><surname>Ueda-Nakamura</surname><given-names>T</given-names></name><name><surname>Dias</surname><given-names>BP</given-names><suffix>Filho</suffix></name><name><surname>Silva</surname><given-names>SO</given-names></name><etal>et al</etal></person-group><article-title>Trypanocidal activity of 1,3,7-trihydroxy-2-(3-methylbut-2-enyl)-xanthone isolated from Kielmeyera coriacea</article-title><source>Parasitol Int</source><year>2013</year><volume>62</volume><issue>5</issue><fpage>405</fpage><lpage>411</lpage><pub-id pub-id-type="pmid">23680754</pub-id></element-citation></ref><ref id="B12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Contreras</surname><given-names>VT</given-names></name><name><surname>Salles</surname><given-names>JM</given-names></name><name><surname>Thomas</surname><given-names>N</given-names></name><name><surname>Morel</surname><given-names>CM</given-names></name><name><surname>Goldenberg</surname><given-names>S</given-names></name></person-group><article-title>In vitro differentiation of Trypanosoma cruzi under chemically defined conditions</article-title><source>Mol Biochem Parasitol</source><year>1985</year><volume>16</volume><issue>3</issue><fpage>315</fpage><lpage>327</lpage><pub-id pub-id-type="pmid">3903496</pub-id></element-citation></ref><ref id="B13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corpas-L&#x000f3;pez</surname><given-names>V</given-names></name><name><surname>Merino-Espinosa</surname><given-names>G</given-names></name><name><surname>D&#x000ed;az-S&#x000e1;ez</surname><given-names>V</given-names></name><name><surname>Morillas-M&#x000e1;rquez</surname><given-names>F</given-names></name><name><surname>Navarro-Moll</surname><given-names>MC</given-names></name><name><surname>Mart&#x000ed;n-S&#x000e1;nchez</surname><given-names>J</given-names></name></person-group><article-title>The sesquiterpene (-)-&#x003b1;-bisabolol is active against the causative agents of Old World cutaneous leishmaniasis through the induction of mitochondrial-dependent apoptosis</article-title><source>Apoptosis</source><year>2016</year><volume>21</volume><issue>10</issue><fpage>1071</fpage><lpage>1081</lpage><pub-id pub-id-type="pmid">27539477</pub-id></element-citation></ref><ref id="B14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coura</surname><given-names>JR</given-names></name><name><surname>Castro</surname><given-names>SL</given-names></name></person-group><article-title>A critical review on Chagas disease chemotherapy</article-title><source>Mem Inst Oswaldo Cruz</source><year>2002</year><volume>97</volume><issue>1</issue><fpage>3</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">11992141</pub-id></element-citation></ref><ref id="B15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>TL</given-names></name><name><surname>Scherwinski-Pereira</surname><given-names>JE</given-names></name></person-group><article-title>In vitro conservation of Piper aduncum and Piper hispidinervum under slow-growth conditions</article-title><source>Pesq Agropec Bras</source><year>2011</year><volume>46</volume><issue>4</issue><fpage>384</fpage><lpage>389</lpage></element-citation></ref><ref id="B16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Docampo</surname><given-names>R</given-names></name><name><surname>Moreno</surname><given-names>SNJ</given-names></name></person-group><article-title>The metabolism and mode of action of gentian violet</article-title><source>Drug Metab Rev</source><year>1990</year><volume>22</volume><issue>2-3</issue><fpage>161</fpage><lpage>178</lpage><pub-id pub-id-type="pmid">2272286</pub-id></element-citation></ref><ref id="B17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Escobar</surname><given-names>P</given-names></name><name><surname>Leal</surname><given-names>SM</given-names></name><name><surname>Herrera</surname><given-names>LV</given-names></name><name><surname>Martinez</surname><given-names>JR</given-names></name><name><surname>Stashenko</surname><given-names>E</given-names></name></person-group><article-title>Chemical composition and antiprotozoal activities of Colombian Lippia spp essential oils and their major components</article-title><source>Mem Inst Oswaldo Cruz</source><year>2010</year><volume>105</volume><issue>2</issue><fpage>184</fpage><lpage>190</lpage><pub-id pub-id-type="pmid">20428679</pub-id></element-citation></ref><ref id="B18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esperandim</surname><given-names>VR</given-names></name><name><surname>Ferreira</surname><given-names>DS</given-names></name><name><surname>Rezende</surname><given-names>KCS</given-names></name><name><surname>Magalh&#x000e3;es</surname><given-names>LG</given-names></name><name><surname>Souza</surname><given-names>JM</given-names></name><name><surname>Pauletti</surname><given-names>PM</given-names></name><etal>et al</etal></person-group><article-title>In vitro antiparasitic activity and chemical composition of the essential oil obtained from the fruits of Piper cubeba</article-title><source>Planta Med</source><year>2013</year><volume>79</volume><issue>17</issue><fpage>1653</fpage><lpage>1655</lpage><pub-id pub-id-type="pmid">24288276</pub-id></element-citation></ref><ref id="B19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fishman</surname><given-names>JA</given-names></name><name><surname>Rubin</surname><given-names>RH</given-names></name></person-group><article-title>Infection in organ-transplant recipients</article-title><source>N Engl J Med</source><year>1998</year><volume>338</volume><issue>24</issue><fpage>1741</fpage><lpage>1751</lpage><pub-id pub-id-type="pmid">9624195</pub-id></element-citation></ref><ref id="B20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flores</surname><given-names>N</given-names></name><name><surname>Jim&#x000e9;nez</surname><given-names>IA</given-names></name><name><surname>Gim&#x000e9;nez</surname><given-names>A</given-names></name><name><surname>Ruiz</surname><given-names>G</given-names></name><name><surname>Guti&#x000e9;rrez</surname><given-names>D</given-names></name><name><surname>Bourdy</surname><given-names>G</given-names></name><etal>et al</etal></person-group><article-title>Antiparasitic activity of prenylated benzoic acid derivatives from Piper species</article-title><source>Phytochemistry</source><year>2009</year><volume>70</volume><issue>5</issue><fpage>621</fpage><lpage>627</lpage><pub-id pub-id-type="pmid">19361822</pub-id></element-citation></ref><ref id="B21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franklim</surname><given-names>TN</given-names></name><name><surname>Freire-de-Lima</surname><given-names>L</given-names></name><name><surname>Diniz</surname><given-names>JNS</given-names></name><name><surname>Previato</surname><given-names>JO</given-names></name><name><surname>Castro</surname><given-names>RN</given-names></name><name><surname>Mendon&#x000e7;a-Previato</surname><given-names>L</given-names></name><etal>et al</etal></person-group><article-title>Design, synthesis and trypanocidal evaluation of novel 1,2,4-triazoles-3-thiones derived from natural piperine</article-title><source>Molecules</source><year>2013</year><volume>18</volume><issue>6</issue><fpage>6366</fpage><lpage>6382</lpage><pub-id pub-id-type="pmid">23760033</pub-id></element-citation></ref><ref id="B22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia</surname><given-names>FP</given-names></name><name><surname>Lazarin-Bid&#x000f3;ia</surname><given-names>D</given-names></name><name><surname>Ueda-Nakamura</surname><given-names>T</given-names></name><name><surname>Silva</surname><given-names>SO</given-names></name><name><surname>Nakamura</surname><given-names>CV</given-names></name></person-group><article-title>Eupomatenoid-5 isolated from leaves of Piper regnellii induces apoptosis in Leishmania amazonensis</article-title><source>Evid Based Complement Alternat Med</source><year>2013</year><volume>2013</volume><size units="pages">940531</size></element-citation></ref><ref id="B23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giddings</surname><given-names>OK</given-names></name><name><surname>Eickhoff</surname><given-names>CS</given-names></name><name><surname>Smith</surname><given-names>TJ</given-names></name><name><surname>Bryant</surname><given-names>LA</given-names></name><name><surname>Hoft</surname><given-names>DF</given-names></name></person-group><article-title>Anatomical route of invasion and protective mucosal immunity in Trypanosoma cruzi conjunctival infection</article-title><source>Infect Immun</source><year>2006</year><volume>74</volume><issue>10</issue><fpage>5549</fpage><lpage>5560</lpage><pub-id pub-id-type="pmid">16988230</pub-id></element-citation></ref><ref id="B24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamedt</surname><given-names>AL</given-names></name><name><surname>Ortiz</surname><given-names>IC</given-names></name><name><surname>Garc&#x000ed;a-Huertas</surname><given-names>PA</given-names></name><name><surname>S&#x000e1;enz</surname><given-names>J</given-names></name><name><surname>Araujo</surname><given-names>AC</given-names></name><name><surname>Mattos</surname><given-names>JC</given-names></name><etal>et al</etal></person-group><article-title>Cytotoxic, mutagenic and genotoxic evaluation of crude extracts and fractions from Piper jericoense with trypanocidal action</article-title><source>Acta Trop</source><year>2014</year><volume>131</volume><fpage>92</fpage><lpage>97</lpage><pub-id pub-id-type="pmid">24361641</pub-id></element-citation></ref><ref id="B25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herwaldt</surname><given-names>BL</given-names></name></person-group><article-title>Laboratory-acquired parasitic infections from accidental exposures</article-title><source>Clin Microbiol Rev</source><year>2001</year><volume>14</volume><issue>4</issue><fpage>659</fpage><lpage>688</lpage><pub-id pub-id-type="pmid">11585780</pub-id></element-citation></ref><ref id="B26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hou&#x000eb;l</surname><given-names>E</given-names></name><name><surname>Gonzalez</surname><given-names>G</given-names></name><name><surname>Bessi&#x000e8;re</surname><given-names>J-M</given-names></name><name><surname>Odonne</surname><given-names>G</given-names></name><name><surname>Eparvier</surname><given-names>V</given-names></name><name><surname>Deharo</surname><given-names>E</given-names></name><etal>et al</etal></person-group><article-title>Therapeutic switching: from antidermatophytic essential oils to new leishmanicidal products</article-title><source>Mem Inst Oswaldo Cruz</source><year>2015</year><volume>110</volume><issue>1</issue><fpage>106</fpage><lpage>113</lpage><pub-id pub-id-type="pmid">25742270</pub-id></element-citation></ref><ref id="B27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inacio</surname><given-names>JD</given-names></name><name><surname>Canto-Cavalheiro</surname><given-names>MM</given-names></name><name><surname>Menna-Barreto</surname><given-names>RF</given-names></name><name><surname>Almeida-Amaral</surname><given-names>EE</given-names></name></person-group><article-title>Mitochondrial damage contribute to epigallocatechin-3-gallate induced death in Leishmania amazonensis</article-title><source>Exp Parasitol</source><year>2012</year><volume>132</volume><issue>2</issue><fpage>151</fpage><lpage>155</lpage><pub-id pub-id-type="pmid">22735546</pub-id></element-citation></ref><ref id="B28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Izumi</surname><given-names>E</given-names></name><name><surname>Ueda-Nakamura</surname><given-names>T</given-names></name><name><surname>Veiga</surname><given-names>VF</given-names><suffix>Jr</suffix></name><name><surname>Pinto</surname><given-names>AC</given-names></name><name><surname>Nakamura</surname><given-names>CV</given-names></name></person-group><article-title>Terpenes from Copaifera demonstrated in vitro antiparasitic and synergic activity</article-title><source>J Med Chem</source><year>2012</year><volume>55</volume><issue>7</issue><fpage>2994</fpage><lpage>3001</lpage><pub-id pub-id-type="pmid">22440015</pub-id></element-citation></ref><ref id="B29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jackson</surname><given-names>Y</given-names></name><name><surname>Myers</surname><given-names>C</given-names></name><name><surname>Diana</surname><given-names>A</given-names></name><name><surname>Marti</surname><given-names>HP</given-names></name><name><surname>Wolff</surname><given-names>H</given-names></name><name><surname>Chappuis</surname><given-names>F</given-names></name><etal>et al</etal></person-group><article-title>Congenital transmission of Chagas disease in Latin American immigrants in Switzerland</article-title><source>Emerg Infect Dis</source><year>2009</year><volume>15</volume><issue>4</issue><fpage>601</fpage><lpage>603</lpage><pub-id pub-id-type="pmid">19331743</pub-id></element-citation></ref><ref id="B30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knobloch</surname><given-names>K</given-names></name><name><surname>Pauli</surname><given-names>A</given-names></name><name><surname>Iberl</surname><given-names>B</given-names></name><name><surname>Weigand</surname><given-names>H</given-names></name><name><surname>Weis</surname><given-names>N</given-names></name></person-group><article-title>Antibacterial and antifungal properties of essential oil components</article-title><source>J Essent Oil Res</source><year>1989</year><volume>1</volume><issue>3</issue><fpage>119</fpage><lpage>128</lpage></element-citation></ref><ref id="B31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>SQ</given-names></name><name><surname>Scott</surname><given-names>IM</given-names></name><name><surname>Pelletier</surname><given-names>Y</given-names></name><name><surname>Kramp</surname><given-names>K</given-names></name><name><surname>Durst</surname><given-names>T</given-names></name><name><surname>Sims</surname><given-names>SR</given-names></name><etal>et al</etal></person-group><article-title>Dillapiol: a pyrethrum synergist for control of the Colorado potato beetle</article-title><source>J Econ Entomol</source><year>2014</year><volume>107</volume><issue>2</issue><fpage>797</fpage><lpage>805</lpage><pub-id pub-id-type="pmid">24772563</pub-id></element-citation></ref><ref id="B32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopes</surname><given-names>AA</given-names></name><name><surname>L&#x000f3;pez</surname><given-names>SN</given-names></name><name><surname>Regasini</surname><given-names>LO</given-names></name><name><surname>Batista</surname><given-names>JM</given-names><suffix>Jr</suffix></name><name><surname>Ambr&#x000f3;sio</surname><given-names>DL</given-names></name><name><surname>Kato</surname><given-names>MJ</given-names></name><etal>et al</etal></person-group><article-title>In vitro activity of compounds isolated from Piper crassinervium against Trypanosoma cruzi</article-title><source>Nat Prod Res</source><year>2008</year><volume>22</volume><issue>12</issue><fpage>1040</fpage><lpage>1046</lpage><pub-id pub-id-type="pmid">18780244</pub-id></element-citation></ref><ref id="B33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>DL</given-names></name><name><surname>Goodhew</surname><given-names>B</given-names></name><name><surname>Czaicki</surname><given-names>N</given-names></name><name><surname>Foster</surname><given-names>K</given-names></name><name><surname>Rajbhandary</surname><given-names>S</given-names></name><name><surname>Hunter</surname><given-names>S</given-names></name><etal>et al</etal></person-group><article-title>Trypanosoma cruzi survival following cold storage: possible implications for tissue banking</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><issue>4</issue><elocation-id>e95398</elocation-id><pub-id pub-id-type="pmid">24759837</pub-id></element-citation></ref><ref id="B34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monzote</surname><given-names>L</given-names></name><name><surname>Garc&#x000ed;a</surname><given-names>M</given-names></name><name><surname>Montalvo</surname><given-names>AM</given-names></name><name><surname>Scull</surname><given-names>R</given-names></name><name><surname>Miranda</surname><given-names>M</given-names></name></person-group><article-title>Chemistry, cytotoxicity and antileishmanial activity of the essential oil from Piper auritum</article-title><source>Mem Inst Oswaldo Cruz</source><year>2010</year><volume>105</volume><issue>2</issue><fpage>168</fpage><lpage>173</lpage><pub-id pub-id-type="pmid">20428676</pub-id></element-citation></ref><ref id="B35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Navickiene</surname><given-names>HMD</given-names></name><name><surname>Morandim</surname><given-names>AA</given-names></name><name><surname>Al&#x000e9;cio</surname><given-names>AC</given-names></name><name><surname>Regasini</surname><given-names>LO</given-names></name><name><surname>Bergamo</surname><given-names>DCB</given-names></name><name><surname>Telascrea</surname><given-names>M</given-names></name><etal>et al</etal></person-group><article-title>Composition and antifungal activity of essential oils from Piper aduncum, Piper arboreum and Piper tuberculatum</article-title><source>Quim Nova</source><year>2006</year><volume>29</volume><issue>3</issue><fpage>467</fpage><lpage>470</lpage></element-citation></ref><ref id="B36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliveira</surname><given-names>GL</given-names></name><name><surname>Cardoso</surname><given-names>SK</given-names></name><name><surname>Lara</surname><given-names>CR</given-names><suffix>Jr</suffix></name><name><surname>Vieira</surname><given-names>TM</given-names></name><name><surname>Guimar&#x000e3;es</surname><given-names>EF</given-names></name><name><surname>Figueiredo</surname><given-names>LS</given-names></name><etal>et al</etal></person-group><article-title>Chemical study and larvicidal activity against Aedes aegypti of essential oil of Piper aduncum L. (Piperaceae)</article-title><source>An Acad Bras Cienc</source><year>2013</year><volume>85</volume><issue>4</issue><fpage>1227</fpage><lpage>1234</lpage><pub-id pub-id-type="pmid">24270836</pub-id></element-citation></ref><ref id="B37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliveira</surname><given-names>JCS</given-names></name><name><surname>Dias</surname><given-names>IJM</given-names></name><name><surname>Camara</surname><given-names>CAG</given-names></name><name><surname>Schwartz</surname><given-names>MOE</given-names></name></person-group><article-title>Volatile constituents of the leaf oils of Piper aduncum L. from different regions of Pernambuco (Northeast of Brazil)</article-title><source>J Essent Oil Res</source><year>2006</year><volume>18</volume><issue>5</issue><fpage>557</fpage><lpage>559</lpage></element-citation></ref><ref id="B38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orjala</surname><given-names>J</given-names></name><name><surname>Wright</surname><given-names>AD</given-names></name><name><surname>Behrends</surname><given-names>H</given-names></name><name><surname>Folkers</surname><given-names>G</given-names></name><name><surname>Sticher</surname><given-names>O</given-names></name><name><surname>R&#x000fc;egger</surname><given-names>H</given-names></name><etal>et al</etal></person-group><article-title>Cytotoxic and antibacterial dihydrochalcones from Piper aduncum</article-title><source>J Nat Prod</source><year>1994</year><volume>57</volume><issue>1</issue><fpage>18</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">8158163</pub-id></element-citation></ref><ref id="B39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raj&#x000e3;o</surname><given-names>MA</given-names></name><name><surname>Furtado</surname><given-names>C</given-names></name><name><surname>Alves</surname><given-names>CL</given-names></name><name><surname>Passos-Silva</surname><given-names>DG</given-names></name><name><surname>Moura</surname><given-names>MB</given-names></name><name><surname>Schamber-Reis</surname><given-names>BL</given-names></name><etal>et al</etal></person-group><article-title>Unveiling benznidazole&#x02019;s mechanism of action through overexpression of DNA repair</article-title><source>Environ Mol Mutagen</source><year>2014</year><volume>55</volume><issue>4</issue><fpage>309</fpage><lpage>321</lpage><pub-id pub-id-type="pmid">24347026</pub-id></element-citation></ref><ref id="B40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramirez</surname><given-names>LE</given-names></name><name><surname>Lages-Silva</surname><given-names>E</given-names></name><name><surname>Pianetti</surname><given-names>GM</given-names></name><name><surname>Rabelo</surname><given-names>RM</given-names></name><name><surname>Bordin</surname><given-names>JO</given-names></name><name><surname>Moraes-Souza</surname><given-names>H</given-names></name></person-group><article-title>Prevention of transfusion-associated Chagas&#x02019; disease by sterilization of Trypanosoma cruzi-infected blood with gentian violet, ascorbic acid, and light</article-title><source>Transfusion</source><year>1995</year><volume>35</volume><issue>3</issue><fpage>226</fpage><lpage>230</lpage><pub-id pub-id-type="pmid">7878715</pub-id></element-citation></ref><ref id="B41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rassi</surname><given-names>A</given-names></name><name><surname>Dias</surname><given-names>JCP</given-names></name><name><surname>Marin</surname><given-names>JA</given-names><suffix>Neto</suffix></name><name><surname>Rassi</surname><given-names>A</given-names></name></person-group><article-title>Challenges and opportunities for primary, secondary, and tertiary prevention of Chagas&#x02019; disease</article-title><source>Heart</source><year>2009</year><volume>95</volume><issue>7</issue><fpage>524</fpage><lpage>534</lpage><pub-id pub-id-type="pmid">19131444</pub-id></element-citation></ref><ref id="B42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Regasini</surname><given-names>LO</given-names></name><name><surname>Cotinguiba</surname><given-names>F</given-names></name><name><surname>Passerini</surname><given-names>GD</given-names></name><name><surname>Bolzani</surname><given-names>VS</given-names></name><name><surname>Cicarelli</surname><given-names>RMB</given-names></name><name><surname>Kato</surname><given-names>MJ</given-names></name><etal>et al</etal></person-group><article-title>Trypanocidal activity of Piper arboreum and Piper tuberculatum (Piperaceae)</article-title><source>Rev Bras Farmacogn</source><year>2009</year><volume>19</volume><issue>1B</issue><fpage>199</fpage><lpage>203</lpage></element-citation></ref><ref id="B43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ribeiro</surname><given-names>GA</given-names></name><name><surname>Cunha</surname><given-names>EF</given-names><suffix>J&#x000fa;nior</suffix></name><name><surname>Pinheiro</surname><given-names>RO</given-names></name><name><surname>da-Silva</surname><given-names>SA</given-names></name><name><surname>Canto-Cavalheiro</surname><given-names>MM</given-names></name><name><surname>Silva</surname><given-names>AJ</given-names></name><etal>et al</etal></person-group><article-title>LQB-118, an orally active pterocarpanquinone, induces selective oxidative stress and apoptosis in Leishmania amazonensis</article-title><source>J Antimicrob Chemother</source><year>2013</year><volume>68</volume><issue>4</issue><fpage>789</fpage><lpage>799</lpage><pub-id pub-id-type="pmid">23288404</pub-id></element-citation></ref><ref id="B44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romanha</surname><given-names>AJ</given-names></name><name><surname>Castro</surname><given-names>SL</given-names></name><name><surname>Soeiro</surname><given-names>MNC</given-names></name><name><surname>Lannes-Vieira</surname><given-names>J</given-names></name><name><surname>Ribeiro</surname><given-names>I</given-names></name><name><surname>Talvani</surname><given-names>A</given-names></name><etal>et al</etal></person-group><article-title>In vitro and in vivo experimental models for drug screening and development for Chagas disease</article-title><source>Mem Inst Oswaldo Cruz</source><year>2010</year><volume>105</volume><issue>2</issue><fpage>233</fpage><lpage>238</lpage><pub-id pub-id-type="pmid">20428688</pub-id></element-citation></ref><ref id="B45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salomon</surname><given-names>CJ</given-names></name></person-group><article-title>First century of Chagas&#x02019; disease: an overview on novel approaches to nifurtimox and benznidazole delivery systems</article-title><source>J Pharm Sci</source><year>2012</year><volume>101</volume><issue>3</issue><fpage>888</fpage><lpage>894</lpage><pub-id pub-id-type="pmid">22161779</pub-id></element-citation></ref><ref id="B46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santoro</surname><given-names>GF</given-names></name><name><surname>Cardoso</surname><given-names>MG</given-names></name><name><surname>Guimar&#x000e3;es</surname><given-names>LG</given-names></name><name><surname>Freire</surname><given-names>JM</given-names></name><name><surname>Soares</surname><given-names>MJ</given-names></name></person-group><article-title>Anti-proliferative effect of the essential oil of Cymbopogon citratus (DC) Stapf (lemongrass) on intracellular amastigotes, bloodstream trypomastigotes and culture epimastigotes of Trypanosoma cruzi (Protozoa: Kinetoplastida)</article-title><source>Parasitology</source><year>2007a</year><volume>134</volume><issue>Pt 11</issue><fpage>1649</fpage><lpage>1656</lpage><pub-id pub-id-type="pmid">17686189</pub-id></element-citation></ref><ref id="B47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santoro</surname><given-names>GF</given-names></name><name><surname>Cardoso</surname><given-names>MG</given-names></name><name><surname>Guimar&#x000e3;es</surname><given-names>LG</given-names></name><name><surname>Mendon&#x000e7;a</surname><given-names>LZ</given-names></name><name><surname>Soares</surname><given-names>MJ</given-names></name></person-group><article-title>Trypanosoma cruzi: activity of essential oils from Achillea millefolium L., Syzygium aromaticum L. and Ocimum basilicum L. on epimastigotes and trypomastigotes</article-title><source>Exp Parasitol</source><year>2007b</year><volume>116</volume><issue>3</issue><fpage>283</fpage><lpage>290</lpage><pub-id pub-id-type="pmid">17349626</pub-id></element-citation></ref><ref id="B48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmunis</surname><given-names>GA</given-names></name><name><surname>Yadon</surname><given-names>ZE</given-names></name></person-group><article-title>Chagas disease: a Latin American health problem becoming a world health problem</article-title><source>Acta Trop</source><year>2010</year><volume>115</volume><issue>1-2</issue><fpage>14</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">19932071</pub-id></element-citation></ref><ref id="B49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sikkema</surname><given-names>J</given-names></name><name><surname>Bont</surname><given-names>JA</given-names></name><name><surname>Poolman</surname><given-names>B</given-names></name></person-group><article-title>Interactions of cyclic hydrocarbons with biological membranes</article-title><source>J Biol Chem</source><year>1994</year><volume>269</volume><issue>11</issue><fpage>8022</fpage><lpage>8028</lpage><pub-id pub-id-type="pmid">8132524</pub-id></element-citation></ref><ref id="B50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>TB</given-names></name><name><surname>Menezes</surname><given-names>LR</given-names></name><name><surname>Sampaio</surname><given-names>MF</given-names></name><name><surname>Meira</surname><given-names>CS</given-names></name><name><surname>Guimar&#x000e3;es</surname><given-names>ET</given-names></name><name><surname>Soares</surname><given-names>MB</given-names></name><etal>et al</etal></person-group><article-title>Chemical composition and anti-Trypanosoma cruzi activity of essential oils obtained from leaves of Xylopia frutescens and X. laevigata (Annonaceae)</article-title><source>Nat Prod Commun</source><year>2013</year><volume>8</volume><issue>3</issue><fpage>403</fpage><lpage>406</lpage><pub-id pub-id-type="pmid">23678822</pub-id></element-citation></ref><ref id="B51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>S&#x000fc;lsen</surname><given-names>VP</given-names></name><name><surname>Puente</surname><given-names>V</given-names></name><name><surname>Papademetrio</surname><given-names>D</given-names></name><name><surname>Batlle</surname><given-names>A</given-names></name><name><surname>Martino</surname><given-names>VS</given-names></name><name><surname>Frank</surname><given-names>FM</given-names></name><etal>et al</etal></person-group><article-title>Mode of action of the sesquiterpene lactones psilostachyin and psilostachyin C on Trypanosoma cruzi.</article-title><source>PLoS ONE</source><year>2016</year><volume>11</volume><issue>3</issue><elocation-id>e0150526</elocation-id><pub-id pub-id-type="pmid">26939119</pub-id></element-citation></ref><ref id="B52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>HT</given-names></name><name><surname>Britta</surname><given-names>EA</given-names></name><name><surname>Longhini</surname><given-names>R</given-names></name><name><surname>Ueda-Nakamura</surname><given-names>T</given-names></name><name><surname>Mello</surname><given-names>JCP</given-names></name><name><surname>Nakamura</surname><given-names>CV</given-names></name></person-group><article-title>Antileishmanial activity of 5-methyl-2,2&#x02019; : 5&#x02019;,2&#x02033;-terthiophene isolated from Porophyllum ruderale is related to mitochondrial dysfunction in Leishmania amazonensis</article-title><source>Planta Med</source><year>2013</year><volume>79</volume><issue>5</issue><fpage>330</fpage><lpage>333</lpage><pub-id pub-id-type="pmid">23457021</pub-id></element-citation></ref><ref id="B53"><element-citation publication-type="report"><person-group person-group-type="author"><collab>WHO - World Health Organization</collab></person-group><source>Chagas disease (American trypanosomiasis). Fact Sheet 340</source><comment>Internet</comment><comment>Updated</comment><month>3</month><year>2016</year><date-in-citation content-type="cited-date">cited 2016 Aug 08</date-in-citation><comment><ext-link ext-link-type="uri" xlink:href="http://www.who.int/mediacentre/factsheets/fs340/en/">http://www.who.int/mediacentre/factsheets/fs340/en/</ext-link></comment></element-citation></ref><ref id="B54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>WH</given-names></name><name><surname>Li</surname><given-names>XC</given-names></name></person-group><article-title>Antifungal compounds from Piper species</article-title><source>Curr Bioact Compd</source><year>2011</year><volume>7</volume><issue>4</issue><fpage>262</fpage><lpage>267</lpage></element-citation></ref></ref-list></back></article>